Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP study

Treatment options for Hepatitis C infection have greatly improved with direct-acting antiviral (DAA) combinations achieving high cure rates. Nevertheless, the cost of this treatment is still high and access to treatment in many countries has been preferentially reserved for patients with more severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Semenova, T., Nemoz, B., Thibault, V., Lagathu, G., Duverlie, G., Brochot, E., Trimoulet, P., Payan, C., Vallet, S., Henquell, C., Chevaliez, S., Bouvier-Alias, M., Maylin, S., Roque-Afonso, A-M., Izquierdo, L., Lunel-Fabiani, F., Marcellin, P., Morand, P., Leroy, V., Larrat, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625182/
https://www.ncbi.nlm.nih.gov/pubmed/31364570
http://dx.doi.org/10.1017/S0950268819001225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625182/
https://www.ncbi.nlm.nih.gov/pubmed/31364570
http://dx.doi.org/10.1017/S0950268819001225

Ejemplares similares